General Information of the Compound
Compound ID
CP0510031
Compound Name
4-(4-Oxo-4H-quinazolin-3-yl)-butyric acid ethyl ester
    Show/Hide
Structure
Formula
C14H16N2O3
Molecular Weight
260.293
Canonical SMILES
CCOC(=O)CCCn1cnc2ccccc2c1=O
    Show/Hide
InChI
InChI=1S/C14H16N2O3/c1-2-19-13(17)8-5-9-16-10-15-12-7-4-3-6-11(12)14(16)18/h3-4,6-7,10H,2,5,8-9H2,1H3
    Show/Hide
InChIKey
YZMWXTKPHGJKNC-UHFFFAOYSA-N
Physicochemical Property
logP
1.7398
Rotatable Bonds
5
Heavy Atom Count
19
Polar Areas
61.19
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10539258
SID: 15565752
ChEMBL ID
CHEMBL124743
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02347, Tumor necrosis factor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000752 PBMC iPSC #1 Homo sapiens (Human)  1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS